Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
The University of Oxford has established a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.
Approximately 300 volunteers will be registered and first inoculations are expected this month, Oxford said.
The two-dose Oxford/AstraZeneca vaccine was hailed as a’vaccine for the world’ because it’s cheaper and easier to distribute than some rivals.
AstraZeneca has a goal to produce 3 billion doses this year and intends to produce over 200 million doses daily by April.
